Patent · US Active

Peptide compound for inhibiting restenosis and promoting re-endothelialization and method for preparing the same

US9603893B2 · kind B2 · utility

0Cited by
0References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 27, 2016
Grant dateMar 28, 2017
Priority date
Expiry dateApr 27, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2420/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are a peptide compound prepared by additional synthesis in a drug having an effect of inhibiting restenosis, a composition for inhibiting restenosis and promoting re-endothelialization including the peptide compound, and a stent having a surface coated by using the composition, in order to overcome a restenosis problem in the stent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.